Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia

被引:288
作者
Paterson, DL
Mulazimoglu, L
Casellas, JM
Ko, WC
Goossens, H
Von Gottberg, A
Mohapatra, S
Trenholme, GM
Klugman, KP
McCormack, JG
Yu, VL
机构
[1] Vet Affairs Med Ctr, Infect Dis Sect, Pittsburgh, PA 15240 USA
[2] Univ Pittsburgh, Pittsburgh, PA 15260 USA
[3] Rush Presbyterian St Lukes Med Ctr, Infect Dis Sect, Chicago, IL 60612 USA
[4] Univ Queensland, Mater Adults Hosp, Dept Med, Brisbane, Qld, Australia
[5] Marmara Univ, Dept Microbiol, Istanbul, Turkey
[6] Sanatorio San Lucas, Dept Infectol & Microbiol, Buenos Aires, DF, Argentina
[7] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 70101, Taiwan
[8] Univ Antwerp Hosp, Dept Microbiol, Antwerp, Belgium
[9] S African Inst Med Res, ZA-2000 Johannesburg, South Africa
关键词
D O I
10.1086/313719
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A prospective study of Klebsiella pneumoniae bacteremia was performed in 12 hospitals in 7 countries, Of 452 episodes of bacteremia, 25 (5.5%) were caused by ii, pneumoniae that was resistant in vitro to ciprofloxacin. Extended-spectrum beta-lactamase (ESBL) production was detected in 15 (60%) of 25 ciprofloxacin-resistant isolates, compared with 68 (16%) of 427 ciprofloxacin-susceptible strains (P = .0001), Multivariate analysis revealed that risk factors for ciprofloxacin resistance in ii. pneumoniae included prior receipt of a quinolone (P = .0065) and an ESBL-producing strain (P = .012), In all, 18% of ESBL-producing isolates were also ciprofloxacin-resistant. Pulsed-held gel electrophoresis showed that 11 of the 15 ciprofloxacin-resistant ESBL-producing strains belonged to just 4 genotypes, suggesting that patient-to-patient transmission of such strains occurred. The close relationship between ESBL production and ciprofloxacin resistance is particularly worrisome because the first reported instance of plasmid-mediated ciprofloxacin resistance has been in an isolate of K. pneumoniae also possessing an ESBL.
引用
收藏
页码:473 / 478
页数:6
相关论文
共 26 条
  • [1] BABINI GS, 1999, 39 INT C ANT AG CHEM, P168
  • [2] Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli
    Bagel, S
    Hüllen, V
    Wiedemann, B
    Heisig, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) : 868 - 875
  • [3] In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: a Canadian multicentre study
    Blondeau, JM
    Yaschuk, Y
    Suter, M
    Vaughan, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 : 3 - 23
  • [4] Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary
    Chow, JW
    Yu, VL
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 11 (01) : 7 - 12
  • [5] In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections
    Deguchi, T
    Kawamura, T
    Yasuda, M
    Nakano, M
    Fukuda, H
    Kato, H
    Kato, N
    Okano, Y
    Kawada, Y
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) : 1609 - 1611
  • [6] Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae
    Deguchi, T
    Fukuoka, A
    Yasuda, M
    Nakano, M
    Ozeki, S
    Kanematsu, E
    Nishino, Y
    Ishihara, S
    Ban, Y
    Kawada, Y
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) : 699 - 701
  • [7] Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones
    Ena, J
    López-Perezagua, MD
    Martínez-Peinado, C
    Cia-Barrio, AD
    Ruíz-López, I
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (02) : 103 - 107
  • [8] MULTICENTER SPANISH STUDY OF CIPROFLOXACIN SUSCEPTIBILITY IN GRAM-NEGATIVE BACTERIA
    GARCIARODRIGUEZ, JA
    FRESNADILLO, MJ
    GARCIA, MIG
    GARCIASANCHEZ, E
    GARCIASANCHEZ, JE
    TRUJILLANO, I
    BAQUERO, F
    BELTRAN, JM
    BOUZA, E
    RODRIGUEZ, M
    BREA, ML
    PICAZO, JJ
    SORIANO, F
    PEREA, E
    DELAROSA, M
    PIEDROLA, G
    LUENGO, FM
    DELOMAS, JG
    GOBERNADO, M
    MARTIN, R
    PRATS, G
    LUS, RG
    AISA, ML
    CISTERNA, R
    RIESTRA, CG
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (05) : 456 - 459
  • [9] CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988
    GARNER, JS
    JARVIS, WR
    EMORI, TG
    HORAN, TC
    HUGHES, JM
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) : 128 - 140
  • [10] Critical appraisal of E test for the detection of fluoroquinolone resistance
    Jones, RN
    Erwin, ME
    Croco, JL
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) : 21 - 25